<![CDATA[FDA Grants Tentative Approval to PNT2003 for GEP-NETs]]>
The FDA granted tentative approval to PNT2003 (lutetium Lu 177 dotatate), a radioequivalent version of lutetium Lu 177 dotatate (Lutathera), for the treatment of adult patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine …